Mastercard

Mastercard committed $25 million in seed funding to the COVID-19 Therapeutics Accelerator, a global initiative in collaboration with Wellcome and the Bill & Melinda Gates Foundation to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments.